The "Europe Osteoarthritis Market and Competitive Landscape 2017" report has been added to Research and Markets' offering.
Europe Osteoarthritis Market and Competitive Landscape 2017, provides comprehensive insights into Osteoarthritis pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Osteoarthritis market size and drug sales. This research also provides insights into Osteoarthritis epidemiology and late stage pipeline.
The report is classified into nine sections Osteoarthritis overview with definitions, symptoms, etiology, diagnosis, treatment options; Osteoarthritis pipeline insights covering late stage clinical trials pipeline; Osteoarthritis prevalence trends by countries; Osteoarthritis market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries.
Research Scope:
- Osteoarthritis pipeline: Find out the drugs in clinical trials for Osteoarthritis by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
- Osteoarthritis epidemiology: Find out the prevalence of Osteoarthritis by countries Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
- Osteoarthritis products: Identify key products marketed and prescribed for Osteoarthritis by brand name, by molecule, by company, by branded generic, by countries Europe, Germany, France, Italy, Spain, UK, Japan
- Osteoarthritis market size: Find out the market size for Osteoarthritis drugs by countries Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
- Osteoarthritis drug sales: Find out the sales of Osteoarthritis drugs by countries Europe, Germany, France, Italy, Spain, UK
- Osteoarthritis drugs sales forecast: Sales forecast for Osteoarthritis drugs to 2021 by countries Europe, Germany, France, Italy, Spain, UK, Japan
- Osteoarthritis market share analysis
For more information about this report visit https://www.researchandmarkets.com/research/k75vts/europe
View source version on businesswire.com: http://www.businesswire.com/news/home/20171130006050/en/
Contacts:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Musculoskeletal Disorders Drugs